D
Doxa AB
STO:DOXA
Doxa AB
STO:DOXA
Price:
0.3995
SEK
-9.82%
Market Closed
Market Cap:
kr513.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Doxa AB
STO:DOXA
|
SE |
|
Dialight PLC
LSE:DIA
|
UK |
Relative Value
The Relative Value of one DOXA stock under the Base Case scenario is 0.0639 SEK. Compared to the current market price of 0.3995 SEK, Doxa AB is Overvalued by 84%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DOXA
Relative Value
Base Case
0.0639
SEK
Overvaluation 84%
D
Multiples Across Competitors
DOXA Competitors Multiples
Doxa AB Competitors
Doxa AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
D
|
Doxa AB
STO:DOXA
|
513.6m SEK | 25.3 | -1.5 | -25.9 | -25.9 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.2T JPY | 10.1 | 36.8 | 26.6 | 31.9 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
55.8B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 3.5 | 37.2 | 14.3 | 27.9 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.2B DKK | 3.5 | 24.3 | 12.8 | 15.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.9B USD | 3.2 | 31.5 | 13.5 | 18.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 33.2 | 11.6 | 18.1 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.2B CNY | 8.3 | 22.9 | 20.6 | 20.6 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 1.1 | -15.5 | 16.8 | 54.5 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
36.8B CNY | 3.6 | 20.7 | 30.4 | 30.4 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
848.5B JPY | 6.5 | 48 | 22.6 | 30.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
